National Stroke Foundation


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved May 1996

Specific Treatments:

growth hormone deficiency, Turner Syndrome

General Information

Saizen has been approved as a treatment for growth hormone deficiency in children. It is also prescribed for the treatment of Turner syndrome, a rare genetic disease, which solely affects girls.